Agapito Fonseca José, Gameiro Joana, Marques Filipe, Lopes José António
Division of Nephrology and Renal Transplantation, Department of Medicine Centro Hospitalar Lisboa Norte, EPE Av. Prof. Egas Moniz, 1649-035 Lisboa, Portugal.
J Clin Med. 2020 May 10;9(5):1413. doi: 10.3390/jcm9051413.
Sepsis-associated acute kidney injury (SA-AKI) is a major issue in medical, surgical and intensive care settings and is an independent risk factor for increased mortality, as well as hospital length of stay and cost. SA-AKI encompasses a proper pathophysiology where renal and systemic inflammation play an essential role, surpassing the classic concept of acute tubular necrosis. No specific treatment has been defined yet, and renal replacement therapy (RRT) remains the cornerstone supportive therapy for the most severe cases. The timing to start RRT, however, remains controversial, with early and late strategies providing conflicting results. This article provides a comprehensive review on the available evidence on the timing to start RRT in patients with SA-AKI.
脓毒症相关急性肾损伤(SA-AKI)是医疗、外科及重症监护环境中的一个主要问题,是死亡率增加、住院时间延长及费用增加的独立危险因素。SA-AKI包含一种适当的病理生理学,其中肾脏和全身炎症起着至关重要的作用,超越了急性肾小管坏死的经典概念。目前尚未确定具体的治疗方法,肾脏替代治疗(RRT)仍然是最严重病例的基石性支持治疗。然而,开始RRT的时机仍存在争议,早期和晚期策略给出了相互矛盾的结果。本文对SA-AKI患者开始RRT时机的现有证据进行了全面综述。